Hongxuan,Jing – Trademark Portfolio

Entity Type: 01

Hongxuan,Jing holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FOTOF, ROSIML, and TIMBOT. The owner is based in Fujian Province.

Rm.2301, Unit 1, Yuheli West Region

Huli District, Xiamen City

Fujian Province 200127 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TIMBOT
TIMBOT
Registered 2020
ROSIML
ROSIML
Registered 2020
FOTOF
FOTOF
Registered 2020

Trademark Classifications

Hongxuan,Jing's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Hongxuan,Jing have?

Hongxuan,Jing has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Hongxuan,Jing file in?

Hongxuan,Jing files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hongxuan,Jing's most well-known trademarks?

Hongxuan,Jing's registered trademark portfolio includes well-known marks such as FOTOF, ROSIML, and TIMBOT. These are among 3 currently registered trademarks in the portfolio.

What is Hongxuan,Jing's trademark registration success rate?

Hongxuan,Jing has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.